{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:45:17Z","timestamp":1783381517878,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semarthrit.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T20:34:04Z","timestamp":1590438844000},"page":"636-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review"],"prefix":"10.1016","volume":"50","author":[{"given":"A","family":"Betrains","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Vanderschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semarthrit.2020.05.002_bib0001","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaci.2014.07.050","article-title":"Myeloid lineage\u2013restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome","volume":"135","author":"de Koning","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.002_bib0002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13075-015-0696-0","article-title":"The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome","volume":"17","author":"de Koning","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.002_bib0003","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2007.09.021","article-title":"IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission","volume":"121","author":"Ryan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.002_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13023-019-1117-2","article-title":"Schnitzler's syndrome-a novel hypothesis of a shared pathophysiologic mechanism with Waldenstr\u00f6m's disease","volume":"14","author":"van Leersum","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.05.002_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0006","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.05.002_bib0007","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.semarthrit.2012.06.003","article-title":"Canakinumab in Schnitzler syndrome","volume":"42","author":"Vanderschueren","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0008","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0009","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses","author":"Wells","year":"2001","journal-title":"Ottawa Hosp Res Inst"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874372201105010031","article-title":"A 51-Year Old Woman with schnitzler syndrome treated with canakinumab","volume":"5","author":"Thomsen","year":"2011","journal-title":"Open Dermatol J"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.05.002_bib0011","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/annrheumdis-2012-202192","article-title":"Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome","volume":"72","author":"de Koning","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.05.002_bib0012","first-page":"E11","article-title":"Successful treatment of Schnitzler syndrome with canakinumab","volume":"94","author":"Pesek","year":"2014","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.002_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","article-title":"Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0014","article-title":"Increasing the interval of canakinumab administration effectively supports the remission of Schnitzler\u2019s syndrome","author":"Gorodetskiy","year":"2018","journal-title":"Case Rep Rheumatol [Internet]"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.12.909","article-title":"Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome","author":"Krause","year":"2020","journal-title":"J Allergy Clin Immunol [Internet]"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.002_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200101000-00004","article-title":"The Schnitzler syndrome: four new cases and review of the literature","volume":"80","author":"Lipsker","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.05.002_bib0017","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler\u2019s syndrome: diagnosis, treatment, and follow\u2010up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.05.002_bib0018","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","article-title":"Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study","volume":"139","author":"Krause","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.05.002_bib0019","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.05.002_bib0020","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10067-018-4119-x","article-title":"Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study","volume":"37","author":"Sota","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0021","unstructured":"Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI). Gecommentarieerd geneesmiddelenrepertorium. [Internet]. Available from: https:\/\/www.bcfi.be\/. [Accessed 12th May 2020]."},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0022","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Base de donn\u00e9es publique des medicaments. [Internet]. Available from: http:\/\/base-donnees-publique.medicaments.gouv.fr\/. [Accessed 12th May 2020]."},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0023","unstructured":"Rote Liste\u00ae Service GmbH. Arzneimittelinformationen f\u00fcr Deutschland. [Internet]. Available from: https:\/\/www.rote-liste.de. [Accessed 12th May 2020]."},{"issue":"3","key":"10.1016\/j.semarthrit.2020.05.002_bib0024","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2011.10.031","article-title":"Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome","volume":"129","author":"Krause","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0025","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.21101","article-title":"Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al","volume":"52","author":"Martinez-Taboada","year":"2005","journal-title":"Arthrit Rheumatism"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.05.002_bib0026","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","article-title":"Beneficial response to anakinra and thalidomide in Schnitzler's syndrome","volume":"65","author":"de Koning","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.05.002_bib0027","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jaad.2006.05.057","article-title":"Prompt response of refractory Schnitzler syndrome to treatment with anakinra","volume":"56","author":"Schneider","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.05.002_bib0028","first-page":"354","article-title":"Successful use of anakinra to treat refractory Schnitzler's syndrome","volume":"26","author":"Dybowski","year":"2008","journal-title":"Clin Exp Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:02:35Z","timestamp":1758733355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0049017220301323"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}